Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Desrayaud

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Macrocyclic BACE-1 inhibitors acutely reduce Abeta in brain after po applicationAndreas Lerchner, Rainer Machauer, Claudia Betschart, et al.
Journal of Medicinal Chemistry|January 4, 2024
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 InhibitorsJuraj Velcicky, Philipp Janser, Nina Gommermann, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2015
Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitorsRobin A Fairhurst, Marc Gerspacher, Patricia Imbach-Weese, et al.
Journal of Medicinal Chemistry|May 2, 2022
Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase InhibitorRobin A Fairhurst, Pascal Furet, Patricia Imbach-Weese, et al.
Journal of Medicinal Chemistry|November 22, 2024
Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 InflammasomeAngela Mackay, Juraj Velcicky, Nina Gommermann, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Macrocyclic BACE-1 inhibitors acutely reduce Abeta in brain after po applicationAndreas Lerchner, Rainer Machauer, Claudia Betschart, et al.
Journal of Medicinal Chemistry|January 4, 2024
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 InhibitorsJuraj Velcicky, Philipp Janser, Nina Gommermann, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2015
Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitorsRobin A Fairhurst, Marc Gerspacher, Patricia Imbach-Weese, et al.
Journal of Medicinal Chemistry|May 2, 2022
Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase InhibitorRobin A Fairhurst, Pascal Furet, Patricia Imbach-Weese, et al.
Journal of Medicinal Chemistry|November 22, 2024
Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 InflammasomeAngela Mackay, Juraj Velcicky, Nina Gommermann, et al.
Pageof 4